Research Article| Volume 48, ISSUE 6, P1205-1210, June 2013

Targeted quantitative amniotic cell profiling: A potential diagnostic tool in the prenatal management of neural tube defects



      We sought to determine whether amniotic cell profiles correlate quantitatively with neural tube defect (NTD) type and/or size.


      Sprague–Dawley fetuses exposed to retinoic acid (n = 61) underwent amniotic fluid sample procurement before term. Samples were analyzed by flow cytometry for the presence of cells concomitantly expressing Nestin and Sox-2 (neural stem cells, aNSCs), and cells concomitantly expressing CD29 and CD44 (mesenchymal stem cells, aMSCs). Statistical analysis included ANOVA and post-hoc Bonferroni adjusted comparisons (P < 0.05).


      There was a statistically significant increase in the proportion of aNSCs in fetuses with spina bifida (6.78% ± 1.87%) when compared to those with exencephaly (0.64% ± 0.23%) or with both spina bifida and exencephaly (0.22% ± 0.09%). Conversely, there was a statistically significant decrease in the proportion of aMSCs in fetuses with exencephaly, either isolated (1.09% ± 0.42%) or in combination defects (2.37% ± 0.63%) when compared with normal fetuses (8.83% ± 1.38%). In fetuses with isolated exencephaly, there was a statistically significant inverse correlation between the proportion of aNSCs and defect size.


      The proportions of neural and mesenchymal stem cells in the amniotic fluid correlate with the type and size of experimental NTDs. Targeted quantitative amniotic cell profiling may become a useful diagnostic tool in the prenatal evaluation of these anomalies.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Boulet S.L.
        • Yang Q.
        • Mai C.
        • et al.
        Trends in the postfortification prevalence of spina bifida and anencephaly in the United States.
        Birth Defects Res A Clin Mol Teratol. 2008; 82: 527-532
        • Adzick N.S.
        • Thom E.A.
        • Spong C.Y.
        • et al.
        A randomized trial of prenatal versus postnatal repair of myelomeningocele.
        N Engl J Med. 2011; 364: 993-1004
        • Danzer E.
        • Schwarz U.
        • Wehrli S.
        • et al.
        Retinoic acid induced myelomeningocele in fetal rats: characterization by histopathological analysis and magnetic resonance imaging.
        Exp Neurol. 2005; 194: 467-475
        • Liptak G.S.
        • Dosa N.P.
        Pediatr Rev. 2010; 31: 443-450
        • Ozyurt H.
        • Totan A.
        • Sahin S.
        • et al.
        Maternal serum and amniotic fluid hydroxyproline levels in neural tube defects.
        Fetal Diagn Ther. 2003; 18: 321-323
        • Kunisaki S.M.
        • Armant M.
        • Kao G.S.
        • et al.
        Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials.
        J Pediatr Surg. 2007; 42 ([discussion 979–80]): 974-979
        • Snyder E.Y.
        • Deitcher D.L.
        • Walsh C.
        • et al.
        Multipotent neural cell lines can engraft and participate in development of mouse cerebellum.
        Cell. 1992; 68: 33-51
        • Snyder E.Y.
        • Yoon C.
        • Flax J.D.
        • et al.
        Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex.
        Proc Natl Acad Sci USA. 1997; 94: 11663-11668
        • Steigman S.A.
        • Armant M.
        • Bayer-Zwirello L.
        • et al.
        Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol.
        J Pediatr Surg. 2008; 43: 1164-1169
        • Turner C.G.
        • Fauza D.O.
        Fetal tissue engineering.
        Clin Perinatol. 2009; 36 (xii): 473-488
        • Turner C.G.
        • Klein J.D.
        • Wang J.
        • et al.
        The amniotic fluid as a source of neural stem cells in the setting of experimental neural tube defects.
        Stem Cells Dev. 2013; 22: 548-553
        • Bonanno E.
        • Mauriello A.
        • Partenzi A.
        • et al.
        Flow cytometry analysis of atherosclerotic plaque cells from human carotids: a validation study.
        Cytometry. 2000; 39: 158-165
        • Adzick N.S.
        • Walsh D.S.
        Myelomeningocele: prenatal diagnosis, pathophysiology and management.
        Semin Pediatr Surg. 2003; 12: 168-174
        • Bianchi D.W.
        • Crombleholme T.M.
        • Alton M.D.
        • et al.
        in: Bianchi D.W. Crombleholme T.M. Alton M.D. Malone F. Fetology: diagnosis and management of the fetal patient. McGraw-Hill, New York2010: 151-165
        • Bianchi D.W.
        • Crombleholme T.M.
        • Alton M.D.
        • et al.
        in: Bianchi D.W. Crombleholme T.M. Alton M.D. Malone F. McGraw-Hill, New York2010: 117-121
        • Korenromp M.J.
        • van Gool J.D.
        • Bruinese H.W.
        • et al.
        Early fetal leg movements in myelomeningocele.
        Lancet. 1986; 1: 917-918
        • Sival D.A.
        • Begeer J.H.
        • Staal-Schreinemachers A.L.
        • et al.
        Perinatal motor behaviour and neurological outcome in spina bifida aperta.
        Early Hum Dev. 1997; 50: 27-37
        • Aaronson O.S.
        • Hernanz-Schulman M.
        • Bruner J.P.
        • et al.
        Myelomeningocele: prenatal evaluation—comparison between transabdominal US and MR imaging.
        Radiology. 2003; 227: 839-843
        • Luthy D.A.
        • Wardinsky T.
        • Shurtleff D.B.
        • et al.
        Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally.
        N Engl J Med. 1991; 324: 662-666
        • Cunderlikova B.
        • Wahlqvist R.
        • Berner A.
        • et al.
        Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
        Cytopathology. 2007; 18: 87-95
        • Enghard P.
        • Humrich J.Y.
        • Rudolph B.
        • et al.
        CXCR3 + CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.
        Arthritis Rheum. 2009; 60: 199-206
        • Gosden C.M.
        • Brock D.J.
        Morphology of rapidly adhering amniotic-fluid cells as an aid to the diagnosis of neural-tube defects.
        Lancet. 1977; 1: 919-922
        • Greenebaum E.
        • Mansukhani M.M.
        • Heller D.S.
        • et al.
        Open neural tube defects: immunocytochemical demonstration of neuroepithelial cells in amniotic fluid.
        Diagn Cytopathol. 1997; 16: 143-144
        • Klein J.D.
        • Turner C.G.
        • Steigman S.A.
        • et al.
        Amniotic mesenchymal stem cells enhance normal fetal wound healing.
        Stem Cells Dev. 2011; 20: 969-976
        • Fauza D.O.
        Amniotic fluid and placental stem cells.
        Best Pract Res Clin Obstet Gynaecol. 2004; 18: 877-891
        • Guzman R.
        • De Los Angeles A.
        • Cheshier S.
        • et al.
        Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model.
        Stroke. 2008; 39: 1300-1306
        • Fauza D.O.
        • Jennings R.W.
        • Teng Y.D.
        • et al.
        Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida.
        Surgery. 2008; 144: 367-373
        • Danzer E.
        • Zhang L.
        • Radu A.
        • et al.
        Amniotic fluid levels of glial fibrillary acidic protein in fetal rats with retinoic acid induced myelomeningocele: a potential marker for spinal cord injury.
        Am J Obstet Gynecol. 2011; 204: 178 e1-11